STAT Plus: FTC approves AbbVie’s $63 million deal for Allergan amid scornful dissent
After months of deliberation, the Federal Trade Commission approved AbbVie’s (ABBV) $63 billion acquisition of…
Category: Pharma
STAT Plus: Pharmalittle: Gilead looks to widen access to remdesivir; ousted BARDA head files whistleblower complaint
Good morning, everyone, and welcome to the middle of the week. Hard to tell, though,…
Gilead signals steps to widen global access to remdesivir for Covid-19 patients
Amid questions about access to remdesivir, its treatment for Covid-19, Gilead Sciences (GILD) says it…
.jpg)
STAT Plus: Pharmalittle: WHO seeking wide access to remdesivir; Gavi proposes incentives for a Covid-19 vaccine
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake
Never in modern times have such high hopes for millions of lives rested on one…
STAT Plus: Orphan drugs improve health — but aren’t priced cost-effectively, study finds
As regulators approve a growing number of orphan drugs, prices for these medicines, which treat small…
STAT Plus: Pharmalittle: Roche wins emergency use nod for coronavirus antibody test; blood pressure drugs don’t raise infection risk
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
Lawmaker asks HHS to ensure Gilead’s remdesivir is affordable if U.S. taxpayers funded R&D
Now that preliminary trial results indicate an experimental Gilead Sciences (GILD) drug can successfully treat…
STAT Plus: Pharmalittle: Gilead faces remdesivir production challenges; will scientists run out of Covid-19 trial patients?
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: What value? High prices for dozens of cancer drugs aren’t tied to better clinical benefits
As payers increasingly demand good value for medicines, a new analysis found that costs for…
STAT Plus: Covid-19 is forcing smaller biotechs to cut spending and change financing plans
The Covid-19 pandemic is taking a harsh toll on small biotech companies, many of which…
STAT Plus: Pharmalittle: U.S. plans ‘Operation Warp Speed’ for a Covid-19 vaccine; Gilead vows remdesivir will be accessible
Top of the morning to you. Despite some gloomy skies and a spot of rain,…
STAT Plus: Watchdog scolds HHS for lacking a big-picture plan to incentivize antibiotic development
Amid growing anxiety over a lack of antibiotics, a new report from a Congressional watchdog…
STAT Plus: Pharmalittle: Pfizer says Covid-19 vaccine could be ready by fall for emergency use; an aggressive pitch to reopen the U.S.
Hello, everyone, and welcome to the middle of the week. Yes, we know, it can…
Hospital demand for hydroxycholoroquine to treat Covid-19 patients is waning
The ongoing uncertainty over whether hydroxycholoroquine can successfully treat Covid-19 appears to have eroded demand…
STAT Plus: Pharmalittle: Japan plans fast-track review of Gilead drug for Covid-19; most Americans think Trump whiffed on drug prices
Rise and shine, everyone, another busy and disorienting day is on the way. Although uncertainty…
STAT Plus: California fines more than a dozen drug makers for not providing drug pricing data
Over the past six months, California state authorities fined more than a dozen drug makers…
STAT Plus: Most Americans believe Trump has failed to make progress lowering drug prices
More than one-third of U.S. adults believe that prescription drug prices have increased a lot…
STAT Plus: Vertex’s new cystic fibrosis drug needs to be far cheaper to be cost-effective, analysis finds
A newly approved treatment from Vertex Pharmaceuticals (VRTX) that targets roughly 90% of all cystic…
STAT Plus: ‘GI tract outside the body’ tests how well oral drugs are absorbed
When people swallow a pill, they expect the medicine to quickly reach the source of…
STAT Plus: Pharmalittle: Arthritis drug disappoints as a Covid-19 treatment; Pepcid is being tested to fight the coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT Plus: Immunotherapy from Regeneron and Sanofi extends survival in non-small cell lung cancer
An immunotherapy from the drug firms Regeneron and Sanofi extended survival in previously untreated patients…
STAT Plus: Gilead sues U.S., claiming it ‘secretly’ obtained patents on HIV research that led to Truvada
Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and “secretly” obtaining…
WHO launches ambitious global project to develop Covid-19 medical products
Led by the World Health Organization, a long list of countries, industry groups, and nongovernmental…
FDA’s Woodcock on authorizing emergency use for hydroxychloroquine: ‘We did the best we could’
Over the past few weeks, the Food and Drug Administration has been criticized for some…
STAT Plus: Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients
And so, another working week will soon draw to a close. This may be hard…
STAT Plus: Pharmalittle: Former BARDA chief charges Trump politicizes science; India may suspend TB drug exports
Hello, everyone, and how are you today? We are doing reasonably well so far, thank…
.jpg)
Poor countries must not be forgotten in the Covid-19 battle, Unitaid director warns
Founded more than a dozen years ago, Unitaid has received more than $3 billion in…
Poor countries must not be forgotten in the Covid-19 battle, Unitaid director warns
Founded more than a dozen years ago, Unitaid has received more than $3 billion in…
STAT Plus: Pharmalittle: Biogen delays Alzheimer’s drug filing; BARDA head leaves amid shakeup
Rise and shine, everyone, another busy and challenging day is on the way. And though…
STAT Plus: FDA warns a company selling an insemination kit with parts only intended for use in animals
Trying to get pregnant can be challenging enough for anxious couples, but imagine being sold…
STAT Plus: Pharmalittle: Trump tones down hydroxycholoroquine hype; U.N. resolution calls for access to Covid-19 products
Good morning, everyone, and how are you today? We are doing okay, thank you, given…
STAT Plus: Despite pricing controversies, pharma’s reputation is improving among patient groups
Even before the pandemic struck and drug makers were seen as potential saviors, the pharmaceutical…
FDA takes another step to ease shortages of drugs for Covid-19 patients on ventilators
The Food and Drug Administration has taken yet another step in a bid to reduce…
STAT Plus: Despite evidence, many primary care doctors don’t want to prescribe medications for addiction
There are widely recommended medicines for treating opioid addiction, but one-third of primary care physicians…
STAT Plus: Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend offered something…
STAT Plus: Drug combination from Exelixis and Bristol-Myers Squibb extends survival in kidney cancer
A two-drug combination of Cabometyx, a once-daily pill, and Opdivo, an anti-cancer immunotherapy, improved the…
Novartis steps up to study of hydroxychloroquine in Covid-19
The drug giant Novartis said Monday it would conduct a 450-person study to determine if…
STAT Plus: An FDA tool for hastening approvals is not very useful for breast cancer drugs
Nearly two years ago, the Food and Drug Administration published a table of surrogate endpoints…
STAT Plus: Dozens of financial firms want pharma to place Covid-19 patients over profits
More than three dozen asset managers, pension funds, and insurers are urging the pharmaceutical industry…
STAT Plus: Pharmalittle: Early data suggests Gilead Covid-19 drug works; did FDA drop standards too far in hunt for chloroquine?
And so, another working week will soon draw to a close. Not a moment too…
FDA eases rules so compounders can make drugs for Covid-19 patients on ventilators
In response to shortages of medicines needed for Covid-19 patients on ventilators, the Food and…
European Union urges the World Health Assembly to pursue a voluntary pool for Covid-19 products
In a significant development, the European Union has proposed a draft resolution urging the World…
STAT Plus: Pharmalittle: More than one coronavirus vaccine may be needed; Utah bill would protect docs prescribing meds for Covid-19
Hello, everyone, and how are you today? We are coping, thank you, despite the ongoing…
STAT Plus: Pharmacy chains gain a ‘solid’ victory in opioid litigation, but aren’t off the hook yet
As jockeying in the opioid litigation continues, a U.S. appeals court ruled several large pharmacy…
As demand surges, half of prescriptions needed for Covid-19 patients on ventilators are going unfilled
As the pandemic continues to spread across the U.S., prescriptions for medicines needed for Covid-19…
STAT Plus: Pharmalittle: Docs ask states for lethal injection drugs to combat Covid-19; Raw material costs for hydroxycholorquine slow production
Good morning, everyone, and how are you today? We are doing all right, under the…
STAT Plus: Startup TScan signs $30m deal with Novartis
TScan Therapeutics on Wednesday announced a $30 million deal with Swiss pharma giant Novartis (NVS)…
STAT Plus: Novo Nordisk becomes latest insulin maker seeking to foster goodwill amid Covid-19
Yet another large insulin maker is trying to soften the financial hit many people are…
STAT Plus: Pharmacy reimbursement often lags for generics undergoing price hikes, jeopardizing patient access
Of more than 4,300 instances in which pharmacies saw generic drug prices rise by 50%…